HomeInvestors HealthAstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy... AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition (AZN:NASDAQ) By BOMAR ENT. March 17, 2025 FacebookTwitterPinterestWhatsApp Roland Magnusson EsoBiotec SA has entered into a definitive agreement to be acquired by AstraZeneca (NASDAQ:AZN) for up to $1 billion, on a cash and debt-free basis, it said on Monday. The deal includes an initial payment of $425 million on closing, and up Source link Previous articleBeating the StreetNext articleKnit Socks!: 17 Classic Patterns for Cozy Feet latest articles explore more Stock Investing for Dummies Options Trading Crash Course: The Complete Crash Course To Learn How Investing And Making Money Online with Trading Options in 7 Days or Less!... Court in Pakistan Orders Recovery of Kidnapped Christian Girl Swing Trading Secrets (38 secrets): A Proven System for Busy Traders to Profit in Just 30 Minutes a Day Where We’d Invest in Real Estate in 2026 (If We Could Buy Anywhere) Stock Trader Black Edition Wine Tumbler 12oz – Trading stocks living – Businessman Financial Advisor Day Trading Stock Market Dividends Investor Finance Profit LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
